Hong Wu

Title: Innovations of Inventor Hong Wu

Introduction

Hong Wu is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals. Her work focuses on the manipulation of erythropoietin and its receptors, which has implications for medical research and therapeutic applications.

Latest Patents

Hong Wu holds a patent titled "Transgenic Mammals Lacking Expression of Erythropoietin or of Erythropoietin Receptor, Transgenic Mammals Expressing Chimeric Erythropoietin Receptors, Constructs for Producing the Transgenic Mammals and Uses Therefor." This patent describes transgenic nonhuman mammals, such as transgenic mice, that lack erythropoietin expression and have deleted erythropoietin receptors. The patent also includes constructs useful for producing these transgenic mammals, embryonic stem cells containing the constructs, and methods for identifying erythropoietin mimics or mimetics.

Career Highlights

Throughout her career, Hong Wu has demonstrated a commitment to advancing scientific knowledge and innovation. Her research has contributed to a better understanding of erythropoietin's role in physiology and its potential therapeutic uses.

Collaborations

Hong Wu has collaborated with esteemed colleagues, including Xin Liu and Harvey F Lodish. These partnerships have enhanced her research and expanded the impact of her work in the scientific community.

Conclusion

Hong Wu's innovative work in the field of transgenic mammals highlights her significant contributions to biotechnology. Her patent and collaborations reflect her dedication to advancing research that can lead to important medical breakthroughs.